Annual Accounts Payable
$9.20 M
-$11.82 M-56.25%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual accounts payable is $9.20 million, with the most recent change of -$11.82 million (-56.25%) on December 31, 2023.
- During the last 3 years, IBRX annual accounts payable has fallen by -$2.31 million (-20.11%).
- IBRX annual accounts payable is now -56.25% below its all-time high of $21.02 million, reached on December 31, 2022.
Performance
IBRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$9.95 M
-$10.37 M-51.05%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly accounts payable is $9.95 million, with the most recent change of -$10.37 million (-51.05%) on September 30, 2024.
- Over the past year, IBRX quarterly accounts payable has dropped by -$10.37 million (-51.05%).
- IBRX quarterly accounts payable is now -70.38% below its all-time high of $33.57 million, reached on March 31, 2023.
Performance
IBRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
IBRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.3% | -51.0% |
| 3 y3 years | -20.1% | -61.0% |
| 5 y5 years | - | -61.0% |
IBRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.3% | at low | -70.4% | +8.2% |
| 5 y | 5-year | -56.3% | at low | -70.4% | +8.2% |
| alltime | all time | -56.3% | at low | -70.4% | +8.2% |
ImmunityBio Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.95 M(-51.1%) |
| Jun 2024 | - | $20.32 M(+46.5%) |
| Mar 2024 | - | $13.87 M(+50.8%) |
| Dec 2023 | $9.20 M(-56.2%) | $9.20 M(-53.6%) |
| Sep 2023 | - | $19.82 M(-22.2%) |
| Jun 2023 | - | $25.49 M(-24.1%) |
| Mar 2023 | - | $33.57 M(+59.7%) |
| Dec 2022 | $21.02 M | $21.02 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $20.24 M(+12.1%) |
| Jun 2022 | - | $18.05 M(+83.6%) |
| Mar 2022 | - | $9.83 M(-13.9%) |
| Dec 2021 | $11.42 M(-0.8%) | $11.42 M(-24.5%) |
| Sep 2021 | - | $15.12 M(-21.1%) |
| Jun 2021 | - | $19.15 M(-4.7%) |
| Mar 2021 | - | $20.10 M(+74.6%) |
| Dec 2020 | $11.51 M | $11.51 M |
FAQ
- What is ImmunityBio annual accounts payable?
- What is the all time high annual accounts payable for ImmunityBio?
- What is ImmunityBio annual accounts payable year-on-year change?
- What is ImmunityBio quarterly accounts payable?
- What is the all time high quarterly accounts payable for ImmunityBio?
- What is ImmunityBio quarterly accounts payable year-on-year change?
What is ImmunityBio annual accounts payable?
The current annual accounts payable of IBRX is $9.20 M
What is the all time high annual accounts payable for ImmunityBio?
ImmunityBio all-time high annual accounts payable is $21.02 M
What is ImmunityBio annual accounts payable year-on-year change?
Over the past year, IBRX annual accounts payable has changed by -$11.82 M (-56.25%)
What is ImmunityBio quarterly accounts payable?
The current quarterly accounts payable of IBRX is $9.95 M
What is the all time high quarterly accounts payable for ImmunityBio?
ImmunityBio all-time high quarterly accounts payable is $33.57 M
What is ImmunityBio quarterly accounts payable year-on-year change?
Over the past year, IBRX quarterly accounts payable has changed by -$10.37 M (-51.05%)